Dr. Howard Colman is a Professor (Tenured) in the Depts. of Neurosurgery, Neurology, and Internal Medicine (Oncology) and holds the Jon M. Huntsman Presidential Chair in Neuro-Oncology. He is Leader of the Neurologic Cancers Center at HCI is also Medical Director of Neuro-Oncology at Intermountain Medical Center. Dr. Colman currently holds a number of leadership positions within HCI including as Co- PI of the Total Cancer Care protocol and Director of the Computational Oncology Research Initiative, among others. Dr. Colman received his M.D. and a Ph.D. in Neuroscience from Washington University School of Medicine in St. Louis, Missouri. He completed a Neuro-Oncology fellowship at the UT MD Anderson Cancer Center in Houston, Texas and is board-certified in Neurology and Neuro-Oncology. Dr. Colman divides his time between patient care and clinical and laboratory research. Dr. Colman’s clinical interests are treatment of primary and metastatic brain tumors and diagnosis and management of neurologic complications of cancer. His clinical research is focused on developing and testing new therapies for brain tumors. His laboratory interests are identification of molecular markers of prognosis and treatment response in brain tumors, and the role of tumor stem cells in the development and treatment of resistance of brain tumors. Dr. Colman has been PI and co-investigator on multiple brain tumor clinical trials and grants and has also served in leadership positions at the local and national levels. He also has a strong interest in the application of novel technologies and informatics in clinical oncology.